Felipe V Gomes Selected Research

Amphetamine (Amfetamine)

1/2022	HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia.
1/2022	GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Felipe V Gomes Research Topics

Disease

21	Schizophrenia (Dementia Praecox) 08/2023 - 10/2014
6	Mental Disorders (Mental Disorder) 05/2023 - 01/2016
5	Catalepsy 01/2023 - 10/2013
4	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2017
3	Hypothermia 01/2023 - 10/2017
2	Substance-Related Disorders (Drug Abuse) 01/2024 - 01/2023
2	Autistic Disorder (Autism) 08/2023 - 01/2017
2	Hyperalgesia 05/2023 - 10/2017
1	Brain Diseases (Brain Disorder) 01/2024
1	Chronic Pain 05/2023
1	Pain (Aches) 05/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Cognitive Dysfunction 01/2022
1	Neurobehavioral Manifestations 04/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Epilepsy (Aura) 01/2017
1	Bradycardia 06/2011
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2010

Drug/Important Bio-Agent (IBA)

8	Dopamine (Intropin)FDA LinkGeneric 08/2023 - 11/2016
7	CannabinoidsIBA 01/2023 - 12/2014
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 10/2014
4	CannabidiolIBA 01/2023 - 10/2013
4	Methylazoxymethanol AcetateIBA 01/2022 - 11/2016
3	gamma-Aminobutyric Acid (GABA)IBA 08/2023 - 01/2020
3	ParvalbuminsIBA 08/2023 - 01/2017
3	Glutamic Acid (Glutamate)FDA Link 01/2022 - 10/2014
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2016
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 07/2010
2	SH-053-2'F-R-CH3IBA 08/2023 - 01/2022
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2022 - 05/2015
2	EndocannabinoidsIBA 01/2022 - 01/2022
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022 - 01/2022
2	CB2 Cannabinoid ReceptorIBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 11/2018 - 01/2017
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 10/2017 - 12/2014
2	5-HT1A Serotonin ReceptorIBA 01/2016 - 10/2013
1	EnzymesIBA 01/2024
1	Metalloproteases (Metalloproteinases)IBA 01/2024
1	Matrix Metalloproteinases (MMPs)IBA 01/2024
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2024
1	Doxycycline (Periostat)FDA LinkGeneric 01/2024
1	GABA-A Receptors (GABA(A) Receptor)IBA 08/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023
1	Levetiracetam (Keppra)FDA LinkGeneric 01/2023
1	Dronabinol (THC)FDA LinkGeneric 01/2023
1	HU-910IBA 01/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 04/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 04/2021
1	methylazoxymethanolIBA 11/2018
1	CarrageenanIBA 10/2017
1	HUF-101IBA 10/2017
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	Therapeutic UsesIBA 01/2017
1	PlasticsIBA 01/2017
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 01/2016
1	Haloperidol (Haldol)FDA LinkGeneric 01/2016
1	Cholinergic AgonistsIBA 06/2011
1	Vasopressins (Vasopressin)IBA 06/2011
1	Carbachol (Carbastat)FDA Link 06/2011
1	Serotonin (5 Hydroxytryptamine)IBA 07/2010

Therapy/Procedure

2	Analgesia 05/2023 - 01/2023
1	Injections 01/2022